Skip to main content

Table 3 Cases where ALTO is clinically superior or inferior to each indicated strategy

From: Long range personalized cancer treatment strategies incorporating evolutionary dynamics

Strategy Inferior 2 Superior 2 Inferior 3 Superior 3
Strategy 0 (Current precision medicine) 5 (0.003 %) 176718 (99.997 %) 1808 (0.2 %) 898155 (99.8 %)
Single step strategy 2.2 5 (0.08 %) 6378 (99.92 %) 5631 (14.5 %) 33093 (85.5 %)
Multi-step strategy 2.2 5 (2.7 %) 179 (97.3 %) 6247 (33.1 %) 12608 (66.9 %)
ALTO-SMO 5 (0.02 %) 32621 (99.98 %) 6313 (10.4 %) 54374 (89.6 %)